Short Title:
VIIP Drug Countermeasure Flight
Responsible HRP Element:
Human Health Countermeasures
Funding Status:
Planned - Task expected to be within budget
|
Procurement Mechanism(s):
|
| NASA Research Announcement |
| Request for Proposals |
| Request for Information |
|
Aims:
Flight testing of the ground validated pharmaceutical countermeasure to determine the efficacy when used during flight to mitigate the VIIP syndrome.
Integration/Unique Aspects:
None
Flight Resources
| Number of Subjects
|
12
|
| When are operations required?
|
Pre/In/Post
|
| When is an approved proposal expected?
|
9/30/2016
|
|
Frequency and type of in-flight sessions:
TBD
|
|
Type of in-flight sessions:
TBD
|
|
Type of in-flight sample collection:
TBD
|
|
Hardware/Software Requirements:
TBD
|
|
BDC Requirements:
TBD
|
Category:
Countermeasures
Subcategory:
Prototype Hardware, Pharmaceutical, Nutritional Supplement
Description:
A validated pharmaceutical countermeasure to mitigate the VIIP syndrome.
Customer:
Space Medicine
Is there a signed Customer-Supplier Agreement?
No
Delivery Milestone:
9/30/2021